|
Age (>45 vs. ≤45 years)
|
2.906
|
0.911–9.268
|
0.071
| | | |
|
Tumor size (>4 vs. ≤4 cm)
|
0.608
|
0.239–1.545
|
0.295
| | | |
|
Tumor grade (1 + 2 vs. 3)
|
1.239
|
0.446–3.441
|
0.681
| | | |
|
SCC antigen level (>1.5 vs. ≤1.5 ng/mL)
|
1.477
|
0.512–4.264
|
0.471
| | | |
|
FIGO stage (IB1 + IB2 + IIA1 vs. IIB)
|
2.111
|
1.313–3.392
|
0.002
|
2.876
|
1.582–5.229
|
0.001
|
|
Pelvic lymph node metastasis (present vs. absent)
|
3.569
|
1.237–10.294
|
0.019
|
0.291
|
0.047–1.789
|
0.183
|
|
Deep cervical stromal invasion (present vs. absent)
|
5.385
|
1.205–24.065
|
0.028
|
1.548
|
0.266–8.999
|
0.626
|
|
Lymphovascular space invasion (present vs. absent)
|
13.212
|
4.575–38.156
|
<0.001
|
19.284
|
5.958–62.419
|
<0.001
|
|
PTK6 expression (high vs. low)
|
4.763
|
1.326–17.112
|
0.017
|
5.999
|
1.622–22.191
|
0.007
|
